RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:we stay
Solid1 wrote: If you look at Medipharm Labs' work, they are the only company in Canada that has correctly assessed the market in the US, and they have an advantage over every other company in Canada. Where exactly is Medipharm Labs' work bad that justifies this price?
I have a hunch that they are no longer considered a "Medical" MJ play, Medical beeing just a disguise word for recreational.
MPL is even though they do the "medical" in all places but a small player in tearms of market share, established thy are a pharmasutical MJ play ( like night and day compared to "medical" )
when people realize that in the US the re schedule of MJ really does nothing for the "medical" MJ company's except possibly the tax breaks I think MPL will start to gain quite a bit of momentum. In the short rearm if many more MJ trials start happening in the US MPL will be the only ones that can supply at this point as none of the other companies have the FDA/DEA accreditation to supply these trials.
I believe the profit margins on Pharma grade MJ are quite high
I think that's where we are but maybe someone can elaborate?!